2. Search Result
Search Result
Results for "

thrombotic thrombocytopenic purpura (TTP)

" in MedChemExpress (MCE) Product Catalog:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P99227
    Caplacizumab

    ALX-0681; ALX-0081

    		 Integrin Transmembrane Glycoprotein Cardiovascular Disease
    Caplacizumab (ALX-0681) is a humanized anti-von Willebrand factor (vWF) nanobody. Caplacizumab inhibits the binding of vWF with platelet glycoprotein (GP) Ibα. Caplacizumab inhibits the vWF-mediated platelet adhesion and prevents further microthrombi formation. Caplacizumab can be used for the research of thrombotic thrombocytopenic purpura (TTP) .
    Caplacizumab